B cell
Showing 9976 - 10000 of >10,000
Pulmonary Arterial Hypertension Trial in Worldwide (UT-15C (treprostinil diolamine))
Completed
- Pulmonary Arterial Hypertension
- UT-15C (treprostinil diolamine)
-
Phoenix, Arizona
- +152 more
May 6, 2022
Obesity, Atherosclerosis Trial in Cairo (pyramidal training by treadmill)
Recruiting
- Obesity
- Atherosclerosis
- pyramidal training by treadmill
-
Cairo, Dokki, EgyptFaculty of Physical Therapy
Oct 5, 2023
Obesity Trial in Cork (Probiotic capsule (L. reuteri PB-W1™), Placebo sachet, Prebiotic sachet (Prebiotic Blend), Placebo
Recruiting
- Obesity
- Probiotic capsule (L. reuteri PB-W1™), Placebo sachet
- +3 more
-
Cork, IrelandUniversity College Cork
Jul 5, 2023
Covid19, Endothelial Dysfunction Trial in Beirut (Endothelial Protocol)
Recruiting
- Covid19
- Endothelial Dysfunction
- Endothelial Protocol
-
Beirut, LebanonLAUMCRH
Mar 22, 2021
Gastric Cancer, Peritoneal Carcinomatosis Trial in Taipei (CRS followed by IP and systemic chemotherapies)
Recruiting
- Gastric Cancer
- Peritoneal Carcinomatosis
- CRS followed by IP and systemic chemotherapies
-
Taipei, TaiwanNational Taiwan University Hospital
Jan 19, 2022
Pancreas Adenocarcinoma Trial in Suwon (Pancreatic ductal adenocarcinoma organoids and cancer-associated fibroblasts
Recruiting
- Pancreas Adenocarcinoma
- Pancreatic ductal adenocarcinoma organoids and cancer-associated fibroblasts establishment group
-
Suwon, Gyeong Gi Do, Korea, Republic ofAjou University Hospital
Oct 7, 2022
Interleukin-7 Serum Level as Biological Marker in Breast Cancer
Completed
- Breast Cancer Invasive
-
Pristina, KosovoFaton I. Sermaxhaj, MD
Mar 18, 2022
Lung Cancer Trial in United States (Paclitaxel, Carboplatin, Bevacizumab)
Corneal Dystrophies, Hereditary Trial in Rotterdam (Descemet Membrane Endothelial Keratoplasty (DMEK))
Completed
- Corneal Dystrophies, Hereditary
- Descemet Membrane Endothelial Keratoplasty (DMEK)
-
Rotterdam, NetherlandsNetherlands Institute for Innovative Ocular Surgery
Jan 11, 2023
Malaria Trial (BNT165e, Placebo)
Not yet recruiting
- Malaria
- BNT165e
- Placebo
- (no location specified)
Sep 29, 2023
HIV Trial in United States (Indinavir sulfate)
Completed
- HIV Infections
- Indinavir sulfate
-
San Francisco, California
- +13 more
Oct 27, 2021
Advanced Biliary Tract Cancer, Neuroendocrine Tumors, Female Reproductive System Tumor Trial in Australia (Ipilimumab,
Recruiting
- Advanced Biliary Tract Cancer
- +3 more
-
Albury, New South Wales, Australia
- +11 more
Oct 31, 2022
Squamous Cell Carcinoma of the Head and Neck Trial (IRX-2, Cyclophosphamide, Indomethacin)
Completed
- Squamous Cell Carcinoma of the Head and Neck
- IRX-2
- +4 more
- (no location specified)
Dec 10, 2020
Non-clear Renal Cell Carcinoma Trial in Nanjing, Nanning (Toripalimab, Axitinib)
Recruiting
- Non-clear Renal Cell Carcinoma
-
Nanjing, Jiangsu, China
- +1 more
Mar 13, 2023
Adjuvant Radiotherapy for pT1b Esophageal Cancer After
Completed
- Esophageal Cancer
-
Beijing, ChinaNational Cancer Center/Cancer Hospital, Chinese Academy of Medic
Aug 10, 2022
Plasma Cell Leukemia Trial in Tianjin (anti-BCMA CAR-T)
Recruiting
- Plasma Cell Leukemia
- anti-BCMA CAR-T
-
Tianjin, ChinaInstitute of Hematology and Blood Diseases Hospital Chinese Acad
May 13, 2023
Allergic Rhinitis Trial in Toronto (AllerPops)
Completed
- Allergic Rhinitis
- AllerPops
-
Toronto, Ontario, CanadaDicentra
Jul 20, 2023
Bladder Cancer, Urothelial Carcinoma Trial in Porto Alegre (Olaparib, Durvalumab)
Terminated
- Bladder Cancer
- Urothelial Carcinoma
-
Porto Alegre, BrazilCentro de Pesquisa em Oncologia
Jun 14, 2021
Analgesia, Obstetrical, Postpartum Hemorrhage, Opioid Use Trial in Cleveland (Ketorolac, Placebo)
Completed
- Analgesia, Obstetrical
- +7 more
- Ketorolac
- Placebo
-
Cleveland, OhioUniversity Hospitals Case Medical Center
May 12, 2022
Acute Myeloid Leukemia (AML) Trial in Hershey (Pevonedistat, transplant, Azacitidine)
Terminated
- Acute Myeloid Leukemia (AML)
- Pevonedistat
- +2 more
-
Hershey, PennsylvaniaPenn State Hershey Medical Center: Penn State Cancer Institute
Nov 22, 2020
Renal Impairment, Hepatic Impairment Trial in Jinan (SIM0417 600 mg; Ritonavir100 mg, SIM0417 375 mg; Ritonavir100 mg, SIM0417
Not yet recruiting
- Renal Impairment
- Hepatic Impairment
- SIM0417 600 mg; Ritonavir100 mg
- +2 more
-
Jinan, Shandong, ChinaShandong Provincial Qianfoshan Hospital
Feb 7, 2023